Biomarin Pharmaceutical Inc BMRN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:38 PM EDT
81.83UNCH (UNCH)
Volume
43,026
Close
81.83quote price arrow down-0.75 (-0.91%)
Volume
1,245,050
52 week range
76.02 - 99.56
Loading...
  • Open82.00
  • Day High83.19
  • Day Low81.79
  • Prev Close82.58
  • 52 Week High99.56
  • 52 Week High Date12/14/23
  • 52 Week Low76.02
  • 52 Week Low Date11/02/23

Key Stats

  • Market Cap15.538B
  • Shares Out189.88M
  • 10 Day Average Volume2.23M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-15.13

KEY STATS

  • Open82.00
  • Day High83.19
  • Day Low81.79
  • Prev Close82.58
  • 52 Week High99.56
  • 52 Week High Date12/14/23
  • 52 Week Low76.02
  • 52 Week Low Date11/02/23
  • Market Cap15.538B
  • Shares Out189.88M
  • 10 Day Average Volume2.23M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-15.13

RATIOS/PROFITABILITY

  • EPS (TTM)1.06
  • P/E (TTM)77.45
  • Fwd P/E (NTM)46.52
  • EBITDA (TTM)282.527M
  • ROE (TTM)4.22%
  • Revenue (TTM)2.472B
  • Gross Margin (TTM)79.22%
  • Net Margin (TTM)8.31%
  • Debt To Equity (MRQ)21.44%

EVENTS

  • Earnings Date07/29/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biomarin Pharmaceutical Inc

 

Profile

MORE
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme...
Richard Meier
Non-Executive Independent Chairman of the Board
Alexander Hardy
President, Chief Executive Officer, Director
Brian Mueller CPA
Chief Financial Officer, Executive Vice President - Finance
Erin Burkhart
Group Vice President, Chief Accounting Officer
C. Greg Guyer Ph.D.
Executive Vice President - Global Manufacturing and Technical Operations, Chief Technical Officer
Address
105 Digital Dr
Novato, CA
94949-8703
United States

Top Peers

SYMBOLLASTCHG%CHG
RPRX
Royalty Pharma PLC
27.99-0.29-1.03%
UTHR
United Therapeutics Corp
261.09-5.13-1.93%
CTLT
Catalent Inc
56.20-0.33-0.58%
IONS
Ionis Pharmaceuticals Inc
40.16-0.77-1.88%
ELAN
Elanco Animal Health Inc
16.89+3.37+24.93%